Literature DB >> 8566843

Ulcerative colitis complicated by renal cell carcinoma: a series of three patients.

J Satsangi1, J Marshall, D Roskell, D Jewell.   

Abstract

Three patients are described in whom renal cell carcinoma was diagnosed between seven months and 14 years after the onset of ulcerative colitis. All three had required treatment with corticosteroids and azathioprine, as well as maintenance therapy with 5-aminosalicylate derivatives, for chronic active colitis. One patient had coexisting polymyalgia rheumatica; one had primary biliary cirrhosis. It is uncertain whether this association, which has not previously been described, has pathogenetic importance or has arisen simply by chance. Genetic predisposition or the effect of drug treatment, particularly immunosuppression, may be pertinent to the co-occurrence of these diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8566843      PMCID: PMC1382994          DOI: 10.1136/gut.38.1.148

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma.

Authors:  M C Yu; T M Mack; R Hanisch; C Cicioni; B E Henderson
Journal:  J Natl Cancer Inst       Date:  1986-08       Impact factor: 13.506

2.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

3.  Severely atypical changes in renal epithelium in biopsy and graft nephrectomy specimens in two cases of cadaver renal transplantation.

Authors:  B V Mittal; R E Cotton
Journal:  Histopathology       Date:  1987-08       Impact factor: 5.087

4.  Genetics of inflammatory bowel disease.

Authors:  J Satsangi; D P Jewell; W M Rosenberg; J I Bell
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

5.  Sulphasalazine induced renal failure.

Authors:  A D Dwarakanath; J Michael; R N Allan
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

6.  A population--based case--control study of renal cell carcinoma.

Authors:  J K McLaughlin; J S Mandel; W J Blot; L M Schuman; E S Mehl; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

7.  Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1).

Authors:  S LaForgia; J Lasota; F Latif; L Boghosian-Sell; K Kastury; M Ohta; T Druck; L Atchison; L A Cannizzaro; G Barnea
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

8.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors:  W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

9.  Mesalazine induced interstitial nephritis.

Authors:  P J Thuluvath; M Ninkovic; J Calam; M Anderson
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

  9 in total
  5 in total

Review 1.  Primary biliary cirrhosis and ulcerative colitis: a case report and review of literature.

Authors:  Wen-Bin Xiao; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Ulcerative colitis associated with primary biliary cirrhosis.

Authors:  M Koulentaki; I E Koutroubakis; E Petinaki; M Tzardi; H Oekonomaki; I Mouzas; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

3.  Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report.

Authors:  Cheryl Cameron; Larry Greenbaum; Thomas Sato; Beth Trost; Brian Lundeen; Michael E Kelly
Journal:  Pediatr Nephrol       Date:  2008-02-20       Impact factor: 3.714

4.  Renal cell carcinoma associated immunosuppressive therapy: a case report with Wegener's granulomatosis.

Authors:  Serpil Muge Deger; Ruya Mutluay; Fatma Ayerden Ebinc; Turgay Arinsoy; Sukru Sindel
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

5.  Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Authors:  Lauranne A A P Derikx; Loes H C Nissen; Joost P H Drenth; Carla M van Herpen; Wietske Kievit; Rob H A Verhoeven; Peter F A Mulders; Christina A Hulsbergen-van de Kaa; Marye J Boers-Sonderen; Tim R A van den Heuvel; Marieke Pierik; Iris D Nagtegaal; Frank Hoentjen
Journal:  Oncotarget       Date:  2015-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.